Atle Fund Management AB NBIX Holdings History
Atle Fund Management AB's Neurocrine Biosciences Inc Holding Summary
As of 2025-06-30, Atle Fund Management AB held 88,392.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $11.11 Mil. This investment constitutes 4.75% of their stock portfolio, and Atle Fund Management AB now holds 0.09% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2022Q4. And since then Atle Fund Management AB has made 7 purchases of NBIX, at an average price of $130.13, for a total of 108,242.00 shares. In addition, there have been 1 sales at an average price of $137.14 for 19,850.00 shares. Based on historical transaction data and NBIX's current price of $134.11, Atle Fund Management AB's estimated gain on his NBIX holdings is $491,026.59, reflecting a 3.49% gain to date.
Atle Fund Management AB NBIX ($134.11) Holding Chart
Atle Fund Management AB NBIX ($134.11) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
